Jane Street
BHVN

Jane Street’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Jane Street’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-30,716
Closed -$4.64M – 10959
2022
Q3 		$4.64M Sell
30,716
-23,278
-43% -$3.45M ﹤0.01% 2738
2022
Q2 		$7.87M Buy
53,994
+42,354
+364% +$5.41M ﹤0.01% 2030
2022
Q1 		$1.38M Sell
11,640
-497
-4% -$62K ﹤0.01% 5452
2021
Q4 		$1.67M Buy
12,137
+4,459
+58% +$567K ﹤0.01% 4836
2021
Q3 		$1.07M Sell
7,678
-78,882
-91% -$9.85M ﹤0.01% 5783
2021
Q2 		$8.4M Buy
86,560
+73,505
+563% +$5.97M ﹤0.01% 1918
2021
Q1 		$893K Sell
13,055
-20,956
-62% -$1.69M ﹤0.01% 5671
2020
Q4 		$2.92M Buy
34,011
+14,439
+74% +$1.22M ﹤0.01% 2855
2020
Q3 		$1.27M Buy
19,572
+15,292
+357% +$1M ﹤0.01% 3703
2020
Q2 		$313K Sell
4,280
-36,329
-89% -$1.93M ﹤0.01% 5776
2020
Q1 		$1.38M Buy
40,609
+28,637
+239% +$1.31M ﹤0.01% 2427
2019
Q4 		$652K Sell
11,972
-2,762
-19% -$137K ﹤0.01% 3357
2019
Q3 		$615K Sell
14,734
-7,870
-35% -$332K ﹤0.01% 3276
2019
Q2 		$990K Buy
+22,604
New +$1.27M ﹤0.01% 2713
2018
Q4 		– Sell
-14,189
Closed -$533K – 6322
2018
Q3 		$533K Sell
14,189
-2,695
-16% -$99.1K ﹤0.01% 3546
2018
Q2 		$667K Buy
16,884
+4,365
+35% +$138K ﹤0.01% 3267
2018
Q1 		$322K Buy
+12,519
New +$374K ﹤0.01% 3938

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

Jane Street's BHVN Position: Q4 2022 in Review

Jane Street sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 30,716 shares — an estimated $4.64M sold.

Jane Street first reported a position in BHVN in Q1 2018 and held it in 17 quarters. The position peaked at $8.4M in Q2 2021. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Jane Street reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Jane Street sold 30,716 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $4.64M.
  • Jane Street first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q1 2018 and held it in 17 quarters.
  • Jane Street's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $8.4M in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Jane Street's 13F filing for Q4 2022, filed 15 Feb 2023.